Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 29

1.

Insulin Resistance Prevents AMPK-induced Tau Dephosphorylation through Akt-mediated Increase in AMPKSer-485 Phosphorylation.

Kim B, Figueroa-Romero C, Pacut C, Backus C, Feldman EL.

J Biol Chem. 2015 Jul 31;290(31):19146-57. doi: 10.1074/jbc.M115.636852. Epub 2015 Jun 22.

2.

Insulin resistance as a key link for the increased risk of cognitive impairment in the metabolic syndrome.

Kim B, Feldman EL.

Exp Mol Med. 2015 Mar 13;47:e149. doi: 10.1038/emm.2015.3. Review.

3.

Diffusion tensor imaging of the sural nerve in normal controls.

Kim B, Srinivasan A, Sabb B, Feldman EL, Pop-Busui R.

Clin Imaging. 2014 Sep-Oct;38(5):648-54. doi: 10.1016/j.clinimag.2014.04.008. Epub 2014 Apr 28.

4.

Hyperglycemia-induced tau cleavage in vitro and in vivo: a possible link between diabetes and Alzheimer's disease.

Kim B, Backus C, Oh S, Feldman EL.

J Alzheimers Dis. 2013;34(3):727-39. doi: 10.3233/JAD-121669.

5.

Insulin resistance in the nervous system.

Kim B, Feldman EL.

Trends Endocrinol Metab. 2012 Mar;23(3):133-41. doi: 10.1016/j.tem.2011.12.004. Epub 2012 Jan 13. Review.

6.

Hyperinsulinemia induces insulin resistance in dorsal root ganglion neurons.

Kim B, McLean LL, Philip SS, Feldman EL.

Endocrinology. 2011 Oct;152(10):3638-47. doi: 10.1210/en.2011-0029. Epub 2011 Aug 2.

7.

Cortical neurons develop insulin resistance and blunted Akt signaling: a potential mechanism contributing to enhanced ischemic injury in diabetes.

Kim B, Sullivan KA, Backus C, Feldman EL.

Antioxid Redox Signal. 2011 May 15;14(10):1829-39. doi: 10.1089/ars.2010.3816. Epub 2011 Mar 8.

8.

How does diabetes accelerate Alzheimer disease pathology?

Sims-Robinson C, Kim B, Rosko A, Feldman EL.

Nat Rev Neurol. 2010 Oct;6(10):551-9. doi: 10.1038/nrneurol.2010.130. Epub 2010 Sep 14. Review.

9.

Increased tau phosphorylation and cleavage in mouse models of type 1 and type 2 diabetes.

Kim B, Backus C, Oh S, Hayes JM, Feldman EL.

Endocrinology. 2009 Dec;150(12):5294-301. doi: 10.1210/en.2009-0695. Epub 2009 Oct 9.

10.

Vascular endothelial growth factor prevents G93A-SOD1-induced motor neuron degeneration.

Lunn JS, Sakowski SA, Kim B, Rosenberg AA, Feldman EL.

Dev Neurobiol. 2009 Nov;69(13):871-84. doi: 10.1002/dneu.20747.

11.

Insulin receptor substrate (IRS)-2, not IRS-1, protects human neuroblastoma cells against apoptosis.

Kim B, Feldman EL.

Apoptosis. 2009 May;14(5):665-73. doi: 10.1007/s10495-009-0331-0.

12.

Insulin-like growth factors in the peripheral nervous system.

Sullivan KA, Kim B, Feldman EL.

Endocrinology. 2008 Dec;149(12):5963-71. doi: 10.1210/en.2008-1020. Epub 2008 Aug 21. Review.

13.

Insulin-like growth factor-I receptor expression regulates neuroblastoma metastasis to bone.

van Golen CM, Schwab TS, Kim B, Soules ME, Su Oh S, Fung K, van Golen KL, Feldman EL.

Cancer Res. 2006 Jul 1;66(13):6570-8.

14.
15.
16.

Cofilin activity during insulin-like growth factor I-stimulated neuroblastoma cell motility.

Meyer G, Kim B, van Golen C, Feldman EL.

Cell Mol Life Sci. 2005 Feb;62(4):461-70.

17.

Integrin-linked kinase complexes with caveolin-1 in human neuroblastoma cells.

Meyer A, van Golen CM, Boyanapalli M, Kim B, Soules ME, Feldman EL.

Biochemistry. 2005 Jan 25;44(3):932-8.

PMID:
15654749
18.

Integrin expression regulates neuroblastoma attachment and migration.

Meyer A, van Golen CM, Kim B, van Golen KL, Feldman EL.

Neoplasia. 2004 Jul-Aug;6(4):332-42.

19.

Insulin-like growth factor-I signaling in human neuroblastoma cells.

Kim B, van Golen CM, Feldman EL.

Oncogene. 2004 Jan 8;23(1):130-41.

PMID:
14712218
20.

Supplemental Content

Loading ...
Support Center